WHO ICTRP trial
TO ASSESS THE SAFETY AND TOLERABILITY OF LIVE MEASLES AND RUBELLA VACCINE INDIA…
CTRI/2012/07/002841 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2012/07/002841 |
|---|---|
| Public title | TO ASSESS THE SAFETY AND TOLERABILITY OF LIVE MEASLES AND RUBELLA VACCINE INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS UNDER FASTING CONDITIONS. |
| Scientific title | AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE, CLINICAL PHASE 1 STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF LIVE MEASLES AND RUBELLA VACCINE, (SINGLE DOSE VIAL FORMULATION) OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS UNDER FASTING CONDITIONS. - MRLSD… |
| Primary sponsor | Cadila Healthcare Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | India |
| Interventions | Intervention1: LIVE MEASLES AND RUBELLA VACCINE, (SINGLE DOSE VIAL FORMULATION): Each 0.5 ml of Measles and Rubella Vaccine (Live), Single dose contains not less than 1000 CCID50 of Measles virus and not less than 1000 CCID50 Rubella virus… |
| Registration date | Jul 30, 2012 |
| Target size | 24 |
| Secondary IDs | MRLSD 1001,Version no 01 dated 02 /07/2011 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: